ESTIMATION OF PREVALENCE OF HEPATITIS C VIRUS INFECTION BY SEROLOGICAL TEST AND REAL TIME RT-PCR TEST AMONG SUSPECTED VIRAL HEPATITIS CASES ATTENDING TERTIARY CARE HOSPITAL, KOLKATA
DOI:
https://doi.org/10.22159/ajpcr.2023v16i9.48161Keywords:
Hepatitis C, sero-prevalence, real time RT-PCR, Sustained virological responseAbstract
Objective: Hepatitis C virus (HCV) infection is a major public health problem in India and worldwide. Majority remain asymptomatic until they develop serious complications like liver cirrhosis or hepatocellular carcinoma with fatal outcome. Hence, early diagnosis of active HCV infection and prompt initiation of treatment is important. Treatment with directly acting antivirals (DAAs) resulted in high sustained virological response (SVR) rates of >95% globally. This study was done to estimate seroprevalence and prevalence of active HCV infection among study population. After initiation of treatment, SVR rates were estimated.
Methods: This was hospital-based, cross-sectional, and observational study. Screening was done by third-generation Enzyme-linked immunosorbent assay to detect anti-HCV antibody, then confirmatory real-time reverse transcription-polymerase chain reaction (RT-PCR) test was done for detection of active cases and determining their viral load. Treatment of 12-week duration was initiated by DAAs and followed up to estimate SVR by doing real-time RT-PCR after 12 weeks of treatment completion.
Result: Among 17,752 consecutive non-repetitive blood samples, seroprevalence was 1.78%. The prevalence of active cases was 1.52%. HCV active infection was prevalent more among male (64.21%) and among 40–60 years age group. History of multiple blood transfusion (58%) was the most common risk factor, followed by multiple sex partners (13.3%). Coinfections with Hepatitis B virus and Human immunodeficiency virus were seen in 13.65% of cases. About 92% of patients completed their treatment. SVR was 97.87%.
Conclusion: High SVR of 97.87% is evidence-based data that support that proper treatment can eliminate HCV infection. Detection by real-time RT-PCR and highly effective DAA has made a paradigm shift to approach of HCV diagnosis and management in recent times
Downloads
References
World Health Organization. A Report about Hepatitis C; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
Sidhu M, Meenia R, Yasmeen I, Sawhney V, Dutt N. Prevalence of transfusion transmitted infections in multiple blood transfused thalassemia patients: A report from a tertiary care center in North India. Ann Trop Med Public Health 2015;8:202-5. doi: 10.4103/1755- 6783.159849
Reddy AK, Murthy KV, Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: Survey by antibody and core antigen detection. Indian J Med Microbiol 2005;23:106-10. doi: 10.4103/0255- 0857.16049, PMID 15928439
Solomon SS, Mehta SH, Srikrishnan AK, Solomon S, McFall AM, Laeyendecker O, et al. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study. Lancet Infect Dis 2015;15:36-45. doi: 10.1016/S1473- 3099(14)71045-X, PMID 25486851
Barua P, Laskar N, Medhi GK, Apum B, Mahanta J. Sexual transmission of hepatitis C virus among female sex workers in India. Int J Infect Dis 2008;12:e416-7. doi: 10.1016/j.ijid.2008.05.1096
Ministry of Health and Family Welfare, Government of India. National Guidelines for Diagnosis and Management of Viral Hepatitis. New Delhi: National Health Mission; 2018. p. 32-8.
Sample Size Calculator by Raosoft, Inc. Raosoft.com. Available from: https://www.raosoft.com/samplesize.html
National Viral Hepatitis Control Program, Ministry of Health and Family Welfare, Government of India; 2018. Available from: https:// www.nhp.gov.in/national-viral-hepatitis-control-program-(nvhcp)_pg
Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, et al. Consensus statement of HCV task force of the Indian national association for study of the liver (INASL). Part I: Status report of HCV infection in India. J Clin Exp Hepatol 2014;4:106-16.
Chakraborty A, Pramanik SB, Singha Roy D, Sarkar S, Chakraborty M, Nandi A. A retrospective study on the seroprevalence of hepatitis C infection in a tertiary care hospital in Kolkata, India. Int J Curr Microbiol Appl Sci 2015;4:115-23.
Rashmi KS, Samreen F, Gopi A, Jain S. Seroprevalence of HCV infection among patients in a tertiary care hospital in Bangalore. J Evol Med Dent Sci 2017;6:2541-4. doi: 10.14260/Jemds/2017/550
Jahan N, Gupta V, Sana M, Mehrotra S, Khatoon R. Prevalence of anti-hepatitis C virus antibodies among indoor patients and blood donors attending a tertiary care hospital in North India. Int J Res Med Sci 2016;4:4256-63.
Jindal N, Bansal R, Grover P, Malhotra R. Risk factors and genotypes of HCV infected patients attending tertiary care hospital in North India. Indian J Med Microbiol 2015;33:189-90. doi: 10.4103/0255- 0857.148440, PMID 25560039
Qamar Z, Anwar F, Ahmad R, Haq I, Haq M, Kashif Khan AM, et al. Prevalence of hepatitis C virus and determination of its genotypes in subjects of Tehsil Daggar district Buner, KP, Pakistan. Clin Epidemiol Glob Health 2021;12:100809. doi: 10.1016/j.cegh.2021.100809
Patel PH, Patel HK, Nerurkar AB. Study of prevalence of hepatitis C virus (HCV) infection in a patients attending tertiary care hospital Valsad, Gujarat, India. Int J Curr Microbiol Appl Sci 2017;6:2783-7. doi: 10.20546/ijcmas.2017.605.312
Published
How to Cite
Issue
Section
Copyright (c) 2023 DR. ASIS KUMAR GHOSH, PROF. DR. RAJA RAY, PROF. DR KALIDAS RIT, BIPASA CHAKRABORTY, DR. SK MAHIUDDIN AHAMMED
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
